Sfoglia per AUTORE
BALLOTTA L
Collezione AOU Novara
Items : 3
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort. in Blood advances / Blood Adv. 2025 Apr 16:bloodadvances.2025015818. doi: 10.1182/bloodadvances.2025015818.
2025
AOU Novara
AOU Novara
Serafin A; Cellini A; Martino EA; Mazzetto F; Angotzi F; Frustaci AM; Marchetti M; Moia R; Sanna A; Riemma C; Cibien F; Noto A; Lista E; Foglietta M; Vitale C; Innao V; Bullo M; Lovato E; Ferrarini I; Andriola C; Ballotta L; Innocenti I; Fresa A; Favrin G; Varettoni M; Santambrogio E; Orsucci L; Pasquale R; Moratti M; et alii...
Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):201-204. doi: 10.1002/hon.3047. Epub 2022 Aug 19.
2023
AOU Città della Salute di Torino
AOU Novara
AOU Città della Salute di Torino
AOU Novara
Foà R; Moia R; Cuneo A; Reda G; Gottardi D; Chiurazzi F; Orsucci L; Maccaferri M; De Paoli L; Marasca R; Ballotta L;
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi. in Frontiers in oncology / Front Oncol. 2021 Dec 6;11:789891. doi: 10.3389/fonc.2021.789891. eCollection 2021.
2021
AOU Novara
AOU Novara
Ballotta L; Zinzani PL; Pileri S; Bruna R; Tani M; Casadei B; Tabanelli V; Volpetti S; Luminari S; Corradini P; Lucchini E; Tisi MC; Merli M; Re A; Varettoni M; Pesce EA; Zaja F;